AzTrials
AzTrials

HIV (Human Immunodeficiency Virus)feSTINCT07516912

Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland

An observational study of HIV (Human Immunodeficiency Virus) and Chlamydia, run by University of Zurich.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The main goal of the observational study is to evaluate participants' satisfaction with free HIV and sexually transmitted infection (STI) testing and counselling offered by the cities of Lucerne and Zurich, Switzerland to young people and people with low incomes. Read more about this study

Who is it for?
Ages 16 years and olderHealthy volunteers can take part
How many people
1,800 participants
Where
No sites listed yet
Study dates
7 Apr 2026to 28 Feb 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: People living in the cities of Lucerne and Zurich, and fullfilling the eligibility criterias of the city programmes either in age or level of income.

Who may be able to join

  • taking part in the pilot programmes
  • understand the study information
  • 16 years of age or older

Who cannot join

  • not eligible for the pilot programmes
  • not understanding the study information
  • less than 16 years old

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Andrea C Farnham, PhD contact

+41 44 634 60 00

testi@ebpi.uzh.ch

About this study

Official title: feSTI: Evaluation of Free HIV and STI Testing and Counselling Services for Young and Disadvantaged Populations in Lucerne and Zurich

The main goal of the observational study is to evaluate participants' satisfaction with free HIV and sexually transmitted infection (STI) testing and counselling offered by the cities of Lucerne and Zurich, Switzerland to young people and people with low incomes. Counselling and testing can be accessed without participating in the study arm of the project.

Keywords
Voluntary counselling and testing, sexually transmitted infections, HIV, implementation of free testing, barriers to care
Medical subject headings
Acquired Immunodeficiency Syndrome, Chlamydia Infections, Gonorrhea, Syphilis, Sexually Transmitted Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07516912
Study groupRoleWhat they receive
Participants in municipal free HIV and STI counselling and testing pilot programmesParticipants are people accessing the municipal free HIV and STI counselling and testing pilot programmes. People can be eligible by age or low income.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participants' satisfaction (study-specific satisfaction scale)

    Participants' satisfaction is measured as the proportion of participants who "agree" or "strongly agree" with satisfaction statements in the post-visit questionnaire. 5-point Likert scale (1 = strongly disagree, 5 = strongly agree); higher scores indicate greater agreement, thus higher satisfaction.

    Measured: 3 years

Secondary outcomes (14)
  1. Service capacity/utilisation

    Number of completed voluntary counselling and testing visits recorded per month across participating sites.

    Measured: 3 years

  2. Access timeliness

    Median number of days between booking date and appointment date for VCT visits

    Measured: 3 years

  3. Workload healthcare providers

    Healthcare provider workload assessed via a short survey measuring perceived workload and time burden, assessed using a standardised Likert-type scale (1-5); higher scores indicate greater perceived workload.

    Measured: 3 years

  4. Count diagnosed HIV/STI cases

    Number of newly diagnosed HIV and STI cases identified through the free voluntary counselling and testing visits across participating sites per reporting period.

    Measured: 3 years

  5. Number of treated STI cases

    Number of participants who received an STI or HIV diagnosis during the pilot project and subsequently received treatment, defined as antibiotics dispensed at a pharmacy or attendance at a medical appointment at Maihof Praxis Lucerne or Checkpoint Zurich.

    Measured: 3 years

  6. Participants' perception of comfort regarding sexual health

    Participant-reported comfort regarding sexual health (encompassing physical, emotional, and social wellbeing related to sexuality and relationships), measured on a visual analogue scale from 0 (not comfortable) to 100 (very comfortable). Filled in at clinic while waiting for appointment and again approximately 1 week after the appointment.

    Measured: 3 years

  7. Testing behaviour

    Testing behaviour assessed via administrative data and self-report. Participants indicate whether this is their first STI/HIV test and, for HIV testing, time since last HIV test. Trends in testing frequency are monitored over the study period.

    Measured: 3 years

  8. Changes in sexual health topics familiarity

    Participants rate 12 topics on a scale from 1 to 5 (1=never heard of it, 5=very familiar); higher scores indicate greater knowledge. Participants rate their familiarity at the clinic prior to the appointment and approximately 1 week after the appointment. The measure is the change between pre- and post-appointment rating.

    Measured: 3 years

  9. Changes in sexual health knowledge

    Knowledge assessed using 8 true/false items (total score range: 0-8), administered at the clinic prior to the appointment and again approximately one week post-appointment. Higher scores indicate greater knowledge. The measure is the change in score from pre- to post-appointment.

    Measured: 3 years

  10. Changes in self-efficacy/attitudes

    Self-efficacy and attitudes assessed using 13 items rated on a 5-point Likert scale (1 = strongly disagree, 5 = strongly agree), administered at the clinic prior to the appointment and again approximately one week post-appointment. Higher scores indicate greater self-efficacy and more positive attitudes. The measure is the change in score from pre- to post-appointment.

    Measured: 3 years

  11. Information-seeking behaviour

    Information-seeking behaviour is assessed using a multiple-choice question identifying sources of sexual health information (e.g., internet, healthcare provider, peers). Reported descriptively as frequency and distribution of sources selected; administered at the clinic prior to the appointment only.

    Measured: 3 years

  12. Proportion of low-income eligible participants

    Proportion of participants holding a KulturLegi card (indicating low-income eligibility) among all enrolled participants; reported descriptively.

    Measured: 3 years

  13. Reach Among Low-Income Eligible Population

    Proportion of KulturLegi card holders enrolled in the study relative to the total number of KulturLegi cards issued in the catchment area during the study period. Assessed by comparing observed reach against a pre-specified target of ≥5% of the eligible low-income population.

    Measured: 3 years

  14. Comparative Outcomes by Eligibility Group

    STI/HIV positivity rates, re-testing rates, and knowledge scores compared between low-income eligible participants (KulturLegi card holders) and age-eligible participants. Differences between groups are reported descriptively; regression modelling may be applied to explore associations and inform policy decisions.

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2026
  2. Study start7 Apr 2026 (estimated)
  3. Primary completion30 Nov 2028 (estimated)
  4. Study completion28 Feb 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
1,800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07516912
Sponsor's protocol ID
feSTI
Other IDs
BASEC-Nr: 2025-02292
Acronym
feSTI
Status last verified
Apr 2026
First submitted
23 Mar 2026
Last updated
8 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared. Access to data is restricted to authorised project personnel. For data sharing partcipant consenst needs to be sought.

Questions about this trial

What is this clinical trial studying?

An observational study of HIV (Human Immunodeficiency Virus) and Chlamydia, run by University of Zurich.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andrea C Farnham, PhD (+41 44 634 60 00, testi@ebpi.uzh.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participants' satisfaction (study-specific satisfaction scale) (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in